Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis - ScienceDirect
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Frontiers | Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
File:Mechanism of action of PDE4 inhibitor.jpg - Wikimedia Commons
Phosphodiesterase-4 inhibitor - Wikipedia
R)-(-)-Rolipram, Selective PDE4 inhibitor (CAS 85416-75-7) (ab120031) | Abcam
An Overview of PDE4 Inhibitors in Clinical Trials | Encyclopedia MDPI
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD | Nature Communications
Phosphodiesterase inhibitor - Wikipedia
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
Phosphodiesterase-4 (PDE4) inhibitors have the potential to suppress... | Download Scientific Diagram
PDE4 as Therapeutic Targets in Different Diseases | Encyclopedia MDPI
Figure 1 from Apremilast : a novel PDE 4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
PDE4 subtypes in cancer | Oncogene
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders - ScienceDirect
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
FCPR03 is a Selective Phosphodiesterase 4 (PDE4) Inhibitor - Immune System Research
PDE4 Inhibitors and Psoriasis: How Do They Affect You? | MyPsoriasisTeam
PDE4 inhibitors in COPDFa more selective approach to treatment
PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease: Trends in Pharmacological Sciences
Molecules | Free Full-Text | An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Phosphodiesterase 4 inhibitors | Semantic Scholar
